BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 32593130)

  • 1. Fabrication of chlorambucil loaded graphene- oxide nanocarrier and its application for improved antitumor activity.
    Singh G; Nenavathu BP; Imtiyaz K; Moshahid A Rizvi M
    Biomed Pharmacother; 2020 Sep; 129():110443. PubMed ID: 32593130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functionalized Graphene Oxide as a nanocarrier of new Copper (II) complexes for targeted therapy on nasopharyngeal carcinoma.
    Li G; Yang Y; Zhou R; Meng F; Li X
    Eur J Pharm Sci; 2018 Oct; 123():249-259. PubMed ID: 29981404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual Drugs Anticancer Nanoformulation using Graphene Oxide-PEG as Nanocarrier for Protocatechuic Acid and Chlorogenic Acid.
    Bullo S; Buskaran K; Baby R; Dorniani D; Fakurazi S; Hussein MZ
    Pharm Res; 2019 Apr; 36(6):91. PubMed ID: 31020429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlorambucil-Loaded Graphene-Oxide-Based Nano-Vesicles for Cancer Therapy.
    Kumari S; Nehra A; Gupta K; Puri A; Kumar V; Singh KP; Kumar M; Sharma A
    Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled quercetin release from high-capacity-loading hyperbranched polyglycerol-functionalized graphene oxide.
    Islami M; Zarrabi A; Tada S; Kawamoto M; Isoshima T; Ito Y
    Int J Nanomedicine; 2018; 13():6059-6071. PubMed ID: 30323593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folate-modified Graphene Oxide as the Drug Delivery System to Load Temozolomide.
    Wang LH; Liu JY; Sui L; Zhao PH; Ma HD; Wei Z; Wang YL
    Curr Pharm Biotechnol; 2020; 21(11):1088-1098. PubMed ID: 32101121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fabrication and characterization of a triple functionalization of graphene oxide with Fe3O4, folic acid and doxorubicin as dual-targeted drug nanocarrier.
    Wang Z; Zhou C; Xia J; Via B; Xia Y; Zhang F; Li Y; Xia L
    Colloids Surf B Biointerfaces; 2013 Jun; 106():60-5. PubMed ID: 23434692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graphene oxide as a nanocarrier for controlled release and targeted delivery of an anticancer active agent, chlorogenic acid.
    Barahuie F; Saifullah B; Dorniani D; Fakurazi S; Karthivashan G; Hussein MZ; Elfghi FM
    Mater Sci Eng C Mater Biol Appl; 2017 May; 74():177-185. PubMed ID: 28254283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immobilization of gold nanoparticles on folate-conjugated dendritic mesoporous silica-coated reduced graphene oxide nanosheets: a new nanoplatform for curcumin pH-controlled and targeted delivery.
    Malekmohammadi S; Hadadzadeh H; Farrokhpour H; Amirghofran Z
    Soft Matter; 2018 Mar; 14(12):2400-2410. PubMed ID: 29512668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cu (II)-porphyrin metal-organic framework/graphene oxide: synthesis, characterization, and application as a pH-responsive drug carrier for breast cancer treatment.
    Gharehdaghi Z; Rahimi R; Naghib SM; Molaabasi F
    J Biol Inorg Chem; 2021 Sep; 26(6):689-704. PubMed ID: 34420089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folate-Conjugated pH-Responsive Nanocarrier Designed for Active Tumor Targeting and Controlled Release of Gemcitabine.
    Pourjavadi A; Tehrani ZM; Moghanaki AA
    Pharm Res; 2016 Feb; 33(2):417-32. PubMed ID: 26438181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functionalized graphene oxides for drug loading, release and delivery of poorly water soluble anticancer drug: A comparative study.
    Karki N; Tiwari H; Pal M; Chaurasia A; Bal R; Joshi P; Sahoo NG
    Colloids Surf B Biointerfaces; 2018 Sep; 169():265-272. PubMed ID: 29783152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of biotin molecule targeted cancer cell drug delivery of doxorubicin loaded κ-carrageenan grafted graphene oxide nanocarrier.
    Vinothini K; Rajendran NK; Munusamy MA; Alarfaj AA; Rajan M
    Mater Sci Eng C Mater Biol Appl; 2019 Jul; 100():676-687. PubMed ID: 30948104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graphene oxide stabilized by PLA-PEG copolymers for the controlled delivery of paclitaxel.
    Angelopoulou A; Voulgari E; Diamanti EK; Gournis D; Avgoustakis K
    Eur J Pharm Biopharm; 2015 Jun; 93():18-26. PubMed ID: 25817600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A facile one-pot synthesis of starch functionalized graphene as nano-carrier for pH sensitive and starch-mediated drug delivery.
    Liu K; Wang Y; Li H; Duan Y
    Colloids Surf B Biointerfaces; 2015 Apr; 128():86-93. PubMed ID: 25731097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Release kinetics from bio-polymeric nanoparticles encapsulating protein synthesis inhibitor- cycloheximide, for possible therapeutic applications.
    Verma AK; Sachin K; Saxena A; Bohidar HB
    Curr Pharm Biotechnol; 2005 Apr; 6(2):121-30. PubMed ID: 15853691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted Delivery of Docetaxel by Use of Transferrin/Poly(allylamine hydrochloride)-functionalized Graphene Oxide Nanocarrier.
    Nasrollahi F; Varshosaz J; Khodadadi AA; Lim S; Jahanian-Najafabadi A
    ACS Appl Mater Interfaces; 2016 Jun; 8(21):13282-93. PubMed ID: 27158834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biocompatible polysaccharide fabricated graphene oxide nanoparticles: A versatile nanodrug carrier to deliver κ- carrageenan against cancer cells.
    Kesavan S; Rajesh D; Shanmugam J; Aruna S; Gopal M; Vijayakumar S
    Int J Biol Macromol; 2023 Jul; 244():125322. PubMed ID: 37307980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and evaluation of galactosylated chitosan/graphene oxide nanoparticles as a drug delivery system.
    Wang C; Zhang Z; Chen B; Gu L; Li Y; Yu S
    J Colloid Interface Sci; 2018 Apr; 516():332-341. PubMed ID: 29408121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sericin grafted multifunctional curcumin loaded fluorinated graphene oxide nanomedicines with charge switching properties for effective cancer cell targeting.
    Jahanshahi M; Kowsari E; Haddadi-Asl V; Khoobi M; Lee JH; Kadumudi FB; Talebian S; Kamaly N; Mehrali M
    Int J Pharm; 2019 Dec; 572():118791. PubMed ID: 31678390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.